These findings highlight the importance of palmitoylation in regulating the stability and localization of Nicastrin and APH‐1 in lipid rafts, and suggest that modulating their palmitoylation status could have implications for the development of therapeutic interventions targeting Aβ aggregation and AD pathology. The gene discussed is NCSTN; the disease is Alzheimer disease.